# Thyroid hormone T3 induces Fyn modification and modulates palmitoyltransferase gene expression through αvβ3 integrin receptor in PC12 cells during hypoxia

**Authors:** Elisabed Kvergelidze, Tamar Barbakadze, Judit Bátor, Irine Kalandadze, David Mikeladze

PMC · DOI: 10.1515/tnsci-2022-0347 · Translational Neuroscience · 2024-08-07

## TL;DR

Thyroid hormone T3 protects nerve-like cells during low oxygen by modifying Fyn through integrin αvβ3, affecting gene expression and cell survival.

## Contribution

This study is the first to show how T3 protects cells during hypoxia via integrin αvβ3, JAK/STAT pathway activation, and altered Fyn modification.

## Key findings

- T3 activates JAK2/STAT5 and suppresses SHP2 in hypoxic PC12 cells via αvβ3 integrin.
- T3 downregulates ZDHHC2 and ZDHHC9 genes, reducing Fyn palmitoylation and phosphorylation.
- These changes may be due to STAT5-dependent epigenetic silencing of palmitoyltransferase genes.

## Abstract

Thyroid hormones (THs) are essential in neuronal and glial cell development and differentiation, synaptogenesis, and myelin sheath formation. In addition to nuclear receptors, TH acts through αvβ3-integrin on the plasma membrane, influencing transcriptional regulation of signaling proteins that, in turn, affect adhesion and survival of nerve cells in various neurologic disorders. TH exhibits protective properties during brain hypoxia; however, precise intracellular mechanisms responsible for the preventive effects of TH remain unclear. In this study, we investigated the impact of TH on integrin αvβ3-dependent downstream systems in normoxic and hypoxic conditions of pheochromocytoma PC12 cells. Our findings reveal that triiodothyronine (T3), acting through αvβ3-integrin, induces activation of the JAK2/STAT5 pathway and suppression of the SHP2 in hypoxic PC12 cells. This activation correlates with the downregulation of the expression palmitoyltransferase-ZDHHC2 and ZDHHC9 genes, leading to a subsequent decrease in palmitoylation and phosphorylation of Fyn tyrosine kinase. We propose that these changes may occur due to STAT5-dependent epigenetic silencing of the palmitoyltransferase gene, which in turn reduces palmitoylation/phosphorylation of Fyn with a subsequent increase in the survival of cells. In summary, our study provides the first evidence demonstrating the involvement of integrin-dependent JAK/STAT pathway, SHP2 suppression, and altered post-translational modification of Fyn in protective effects of T3 during hypoxia.

## Linked entities

- **Genes:** ZDHHC2 (zDHHC palmitoyltransferase 2) [NCBI Gene 51201], ZDHHC9 (zDHHC palmitoyltransferase 9) [NCBI Gene 51114], JAK2 (Janus kinase 2) [NCBI Gene 3717], STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776], PTPN11 (protein tyrosine phosphatase non-receptor type 11) [NCBI Gene 5781]
- **Proteins:** FYN (FYN proto-oncogene, Src family tyrosine kinase)
- **Chemicals:** triiodothyronine (PubChem CID 5920), T3 (PubChem CID 5920)

## Full-text entities

- **Genes:** Zdhhc9 (zDHHC palmitoyltransferase 9) [NCBI Gene 302808], Jak2 (Janus kinase 2) [NCBI Gene 24514], Stat5a (signal transducer and activator of transcription 5A) [NCBI Gene 24918] {aka Stat5}, Ptpn11 (protein tyrosine phosphatase, non-receptor type 11) [NCBI Gene 25622] {aka Shp2}, Th (tyrosine hydroxylase) [NCBI Gene 25085] {aka The}, Zdhhc2 (zDHHC palmitoyltransferase 2) [NCBI Gene 246326] {aka DHHC2, srec}, Fyn (FYN proto-oncogene, Src family tyrosine kinase) [NCBI Gene 25150]
- **Diseases:** pheochromocytoma (MESH:D010673), hypoxia (MESH:D000860), neurologic disorders (MESH:D009461), brain hypoxia (MESH:D002534)
- **Cell lines:** PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11306964/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11306964/full.md

---
Source: https://tomesphere.com/paper/PMC11306964